The developed protocol allows prospective and retrospective molecular and genomic epidemiological investigation of C. difficile infections for infection control purpose.

The aim of this paper is to review current knowledge on the relationship between presumptive infectious agents and neonatal porcine diarrhoea (NPD). The literature provides information on the rationale for this causation, including the first mention, main understandings gained with respect to, e.g., …

CLABSIs, VAEs, and CDIs increased significantly during the pandemic, especially in smaller community hospitals, most of which lack ID physician expertise. Future efforts should focus on better understanding challenges faced by community hospitals, strengthening infection prevention infrastructure, a …

A gastroenterologist, Dr. Paul Feuerstadt, provides an overview of C. difficile infection (CDI) and vegetative and spore phases of CDI.

The COVID-19 pandemic has placed significant burden on healthcare systems. We compared Clostridioides difficile infection (CDI) epidemiology before and during the pandemic across 71 hospitals participating in the Canadian Nosocomial Infection Surveillance System. Using an interrupted time ser …

Molecular epidemiology differed between CA-CDI and HA-CDI and WGS analysis suggests transmission of CDI within and between hospitals and communities.

Clostridioides difficile is a leading cause of healthcare-associated infections worldwide. Currently, there is a lack of consensus for an optimal diagnostic method for C. difficile infection (CDI)....

Editorial: Clostridium difficile infection in the Asia-Pacific region

Contamination was 11.5% on floors, 7.9% on infusion chairs, and 3.8% on equipment.

Clostridioides difficile is one of the most important human pathogens. The identification of its possible sources is important for the understanding of C. difficile infection (CDI) epidemiology. A total of 16 water samples from wastewater and surface water in South Moravia in the Czech Republic and …

Hospitals in Alaska have the lowest Clostridioides difficile infection rate in the country, CDC data shows.

Clostridium Difficile (C. Diff) is the most important public health treat related to antimicrobial resistance. 500,000 infection are being reported annually, having a financial impact to the health system with a cost of $ 4 billion ... #MedTwitter #IM #GI #Cdiff pic.twitter.com/Omz1gLiDXk— Texas Tech Permian Basin Internal Med Residency (@TTechPBIMRes) August 9, 2022

This review describes the current understanding of Clostridium (Clostridioides) difficile infection (CDI) in southeast Asia regarding the prevalence of CDI, C. difficile detection methods, antimicrobial susceptibility profiles, and the potential significance of a One Health approach to prevention an …

Insects are increasingly used as alternative protein sources and ingredients of foodstuffs produced in industrial scale. Previous studies on the microbial status of insect-based foods revealed that classical foodborne pathogens such as Salmonella spp., Campylobacter spp., Listeria monocytogenes or p …

ABSTRACT Clostridioides difficile is a leading cause of healthcare-associated infections worldwide. Currently, there is a lack of consensus for an optimal diagnostic method for C. difficile infection (CDI). Multi-step diagnostic algorithms use enzyme immunosorbent analysis (EIA)- …

The CDI incidence was high in older adults, with severe clinical consequences. SOC specimen collection and testing under-estimated CDI burden. There are 57 000 hospitalized CDI cases per year in Japan in persons ≥50 years-of-age. Public health interventions are needed to reduce the CDI burden in …

This consultation asks for feedback on new guidance for the management and treatment of Clostridioides difficile infection.

Learn where germs live in the healthcare environment to stop their spread.

The COVID-19 pandemic reversed years of progress against antimicrobial resistance in the United States, with resistant hospital-onset infections and deaths both increasing at least 15% during the first year, according to a new CDC report.

Hospital-related infections, deaths rose at least 15% in 2020

Overall prevalence of C. difficile in our healthcare settings was 6%. Antibiotic resistance rates ranged from 72.2% (clindamycin) to 16.6% (tetracycline). This study highlighted a relatively high genetic diversity in term of ribotypes, sequence types, toxin and antibiotic resistance patterns, in the …

Clostridium Difficile Infections Market Report gives readers a thorough assessment of key market drivers restraints prospects opportunities restraints current trends and technological and industrial breakthroughs that will influence market growth The detailed market research industry sector growth and development and ...

Compared to the earlier years 2003-2008, overall CDI outcome improved in the later years 2008-2014. Younger patients increasingly contributed to CDI prevalence, mortality, and severity during 2003-2014. More studies to understand underlying driving forces of changes in CDI trends are warranted to mi …

The CDI incidence was high in older adults, with severe clinical consequences. SOC specimen collection and testing under-estimated CDI burden. There are 57 000 hospitalized CDI cases per year in Japan in persons ≥50 years-of-age. Public health interventions are needed to reduce the CDI burden in …

Dutch ministry of Health.

BackgroundThere is a paucity of data on community-based Clostridioides difficile infection (CDI) and how these compare with inpatient CDI.AimTo compare data on the populations with CDI in hospitals vs the community across 12 European countries.MethodsFor this point-prevalence study (July-Nove …

“RT @ChristianLillis: I'm very proud of this victory; a great step in getting #cdiff to be reported more broadly. Thanks to all of our Advoc…”

Escherichia coli 0157:H7 Outbreak in Children with Clostridioides difficile Colonization Associated with an Improperly Treated Swimming Pool-Pennsylvania, June 2021

The investigational oral microbiome therapeutic SER-109 was found to be safe and effective for the prevention of recurrent CDI.